Download Citation

Article Source: The use of ¹⁸F-Fluoro-deoxy-glucose positron emission tomography (¹⁸F-FDG PET) as a non-invasive pharmacodynamic biomarker to determine the minimally pharmacologically active dose of AZD8835, a novel PI3Kα inhibitor
Maynard J, Emmas SA, Ble FX, Barjat H, Lawrie E, et al. (2017) The use of ¹⁸F-Fluoro-deoxy-glucose positron emission tomography (¹⁸F-FDG PET) as a non-invasive pharmacodynamic biomarker to determine the minimally pharmacologically active dose of AZD8835, a novel PI3Kα inhibitor. PLOS ONE 12(8): e0183048. https://doi.org/10.1371/journal.pone.0183048

Download the article citation in the following formats:

• RIS (compatible with EndNote, Reference Manager, ProCite, RefWorks)
• BibTex (compatible with BibDesk, LaTeX)